Health CarePharmaceuticals & Biotechnology
  • Price (INR)547.20
  • Today's Change-0.75 / -0.14%
  • Shares traded4.48m
  • 1 Year change-25.26%
  • Beta0.0729
Data delayed at least 15 minutes, as of Oct 17 2017 11:28 BST.
More ▼

Key statistics

On Tuesday, Sun Pharmaceutical Industries Ltd (SUNPHARMA:NSI) closed at 547.20, 26.46% above the 52 week low of 432.70 set on Aug 14, 2017.
52-week range
432.70Aug 14 2017759.00Oct 25 2016
Previous close547.95
Average volume4.84m
Shares outstanding2.40bn
Free float1.06bn
P/E (TTM)29.32
Market cap1.31tn INR
EPS (TTM)18.69
Annual div (ADY)3.50
Annual div yield (ADY)0.64%
Div ex-dateSep 18 2017
Div pay-dateOct 26 2017
Data delayed at least 15 minutes, as of Oct 17 2017 11:28 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.